Disciformycins A and B: 12-Membered Macrolide Glycoside Antibiotics from the Myxobacterium Pyxidicoccus fallax Active against Multiresistant Staphylococci

被引:52
作者
Surup, Frank [1 ,3 ]
Viehrig, Konrad [2 ,3 ]
Mohr, Kathrin I. [1 ,3 ]
Herrmann, Jennifer [2 ,3 ]
Jansen, Rolf [1 ,3 ]
Mueller, Rolf [1 ,2 ,3 ]
机构
[1] Helmholtz Ctr Infect Res HZI, Dept Microbial Drugs, D-38124 Braunschweig, Germany
[2] Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, D-66123 Saarbrucken, Germany
[3] German Ctr Infect Res DZIF, Braunschweig, Germany
关键词
antibiotics; biosynthesis; myxobacteria; polyketides; secondary metabolites; DOUBLE-BOND MIGRATION; NMR-SPECTROSCOPY; GENE-CLUSTER; POLYKETIDE; IDENTIFICATION; BIOSYNTHESIS; EPOTHILONE; PREDICTION; DISCOVERY;
D O I
10.1002/anie.201406973
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Two macrolide glycosides with a unique scaffold were isolated from cultures of the myxobacterium Pyxidicoccus fallax. Their structures, including absolute configurations, were elucidated by a combination of NMR, MS, degradation, and molecular modeling techniques. Analysis of the proposed biosynthetic gene cluster led to insights into the biosynthesis of the polyketide and confirmed the structure assignment. The more active compound, disciformycin B, potently inhibits methicillin-and vancomycin-resistant Staphylococcus aureus.
引用
收藏
页码:13588 / 13591
页数:4
相关论文
共 33 条
[31]   IDENTIFICATION OF THE YEAST ACC1 GENE-PRODUCT (ACETYL-COA CARBOXYLASE) AS THE TARGET OF THE POLYKETIDE FUNGICIDE SORAPHEN-A [J].
VAHLENSIECK, HF ;
PRIDZUN, L ;
REICHENBACH, H ;
HINNEN, A .
CURRENT GENETICS, 1994, 25 (02) :95-100
[32]   The impact of genomics on the exploitation of the myxobacterial secondary metabolome [J].
Wenzel, Silke C. ;
Mueller, Rolf .
NATURAL PRODUCT REPORTS, 2009, 26 (11) :1385-1407
[33]   Computational approach for prediction of domain organization and substrate specificity of modular polyketide synthases [J].
Yadav, G ;
Gokhale, RS ;
Mohanty, B .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 328 (02) :335-363